Literature DB >> 26653328

Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.

Johanna Senger1, Jelena Melesina2, Martin Marek3, Christophe Romier3, Ina Oehme4, Olaf Witt4, Wolfgang Sippl2, Manfred Jung1.   

Abstract

Histone deacetylase 6 (HDAC6) catalyzes the removal of an acetyl group from lysine residues of several non-histone proteins. Here we report the preparation of thiazole-, oxazole-, and oxadiazole-containing biarylhydroxamic acids by a short synthetic procedure. We identified them as selective HDAC6 inhibitors by investigating the inhibition of recombinant HDAC enzymes and the protein acetylation in cells by Western blotting (tubulin vs histone acetylation). The most active compounds exhibited nanomolar potency and high selectivity for HDAC6. For example, an oxazole hydroxamate inhibits HDAC6 with an IC50 of 59 nM and has a selectivity index of >200 against HDAC1 and HDAC8. This is the first report showing that the nature of a heterocycle directly connected to a zinc binding group (ZBG) can be used to modulate subtype selectivity and potency for HDAC6 inhibitors to such an extent. We rationalize the high potency and selectivity of the oxazoles by molecular modeling and docking.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26653328     DOI: 10.1021/acs.jmedchem.5b01493

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

Review 1.  Histone Deacetylase Inhibitors: A Prospect in Drug Discovery.

Authors:  Rakesh Yadav; Pooja Mishra; Divya Yadav
Journal:  Turk J Pharm Sci       Date:  2018-12-31

2.  Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.

Authors:  Priya Poonia; Monika Sharma; Prakash Jha; Madhu Chopra
Journal:  Mol Divers       Date:  2022-10-10       Impact factor: 3.364

3.  Histone Deacetylase 6 Inhibitor JS28 Prevents Pathological Gene Expression in Cardiac Myocytes.

Authors:  Vivien Ngo; Bernd K Fleischmann; Manfred Jung; Lutz Hein; Achim Lother
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

Review 4.  Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.

Authors:  Jeremy D Osko; David W Christianson
Journal:  Bioorg Med Chem Lett       Date:  2020-02-11       Impact factor: 2.823

5.  The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.

Authors:  Ahmed T Negmeldin; Joseph R Knoff; Mary Kay H Pflum
Journal:  Eur J Med Chem       Date:  2017-10-31       Impact factor: 6.514

6.  Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.

Authors:  Jeremy D Osko; Nicholas J Porter; Poli Adi Narayana Reddy; You-Cai Xiao; Johanna Rokka; Manfred Jung; Jacob M Hooker; Joseph M Salvino; David W Christianson
Journal:  J Med Chem       Date:  2019-12-19       Impact factor: 7.446

7.  A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors.

Authors:  Laura Goracci; Nathalie Deschamps; Giuseppe Marco Randazzo; Charlotte Petit; Carolina Dos Santos Passos; Pierre-Alain Carrupt; Claudia Simões-Pires; Alessandra Nurisso
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

8.  Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6.

Authors:  Mohamed D M Traoré; Vincent Zwick; Claudia A Simões-Pires; Alessandra Nurisso; Mark Issa; Muriel Cuendet; Marjorie Maynadier; Sharon Wein; Henri Vial; Helene Jamet; Yung-Sing Wong
Journal:  ACS Omega       Date:  2017-04-20

Review 9.  HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?

Authors:  Hélène Losson; Michael Schnekenburger; Mario Dicato; Marc Diederich
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

10.  Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition.

Authors:  Kristina King; Alexander-Thomas Hauser; Jelena Melesina; Wolfgang Sippl; Manfred Jung
Journal:  Molecules       Date:  2018-02-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.